A plaza dedicated and named in honor of Cornell’s 14th president, Martha E. Pollack, will be part of the new Cornell Ann S. Bowers College of Computing and Information Science building and complex, connecting it with Gates Hall.
Big Red Ventures (BRV), Cornell’s early-stage venture capital fund, showcased the student-run portfolio and highlighted 2022-23 investments during the Annual Meeting on April 20 at Cornell Tech.
Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors’ potential to spread, and may even be targets for future prostate cancer treatments, according to a study led by researchers at Weill Cornell Medicine.
Ten Graduate School doctoral candidates, joined by one student from the Weill Cornell Graduate School of Medicine, traveled from Ithaca and New York City to Capitol Hill for Cornell Ph.D. Student Advocacy Day on March 29.
Weill Cornell researchers find inflammatory bowel disease drug works by modulating the activity of a group of gut bacteria that are more abundant in patients who respond to the drug.
A new study found that patients with non-small cell lung cancer treated with a combination of low-dose radiation and immunotherapy had higher progression-free survival compared to patients who received immunotherapy alone.
Entrepreneurs will gather to hear fireside chats with top business leaders, enjoy multiple networking and engagement opportunities and hear startup pitches at Entrepreneurship at Cornell’s Eclectic Convergence 2023.
A consortium aiming to make New York a global leader in artificial intelligence would help Cornell play a role in shaping the future of AI, promote responsible research and development, create jobs and unlock opportunities focused on public good.
How do you solve a problem like a massive decommissioned nuclear power plant only 35 miles north of New York City with no clear future use? This semester, an architecture option studio at the Cornell Gensler Family AAP NYC Center is tackling this very question, imagining an evolution for the facility rather than a demolition.
A confluence of events, combined with a healthy obsession for details and a love of writing, gave Cornell Tech computer scientist Ari Juels just what he needed to produce his second fiction thriller, “The Oracle.”